{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:36:16Z","timestamp":1707525376374},"reference-count":55,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,20]]},"DOI":"10.7759\/cureus.47358","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T07:40:01Z","timestamp":1697787601000},"source":"Crossref","is-referenced-by-count":0,"title":["The Second COVID-19 Wave Is a Tsunami With Aftershocks: Mucormycosis Ire as Seen in a Tertiary Care Hospital in Uttarakhand, India"],"prefix":"10.7759","author":[{"given":"Dimple","family":"Raina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranjana","family":"Rohilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiwang","family":"Patwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay","family":"Pandita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India","volume":"15","author":"Singh AK","year":"2021","unstructured":"Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr. 2021, 15:102146. 10.1016\/j.dsx.2021.05.019","journal-title":"Diabetes Metab Syndr"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009921","article-title":"COVID-19-associated mucormycosis: evidence-based critical review of an emerging infection burden during the pandemic's second wave in India","volume":"15","author":"Aranjani JM","year":"2021","unstructured":"Aranjani JM, Manuel A, Abdul Razack HI, Mathew ST. COVID-19-associated mucormycosis: evidence-based critical review of an emerging infection burden during the pandemic's second wave in India. PLoS Negl Trop Dis. 2021, 15:e0009921. 10.1371\/journal.pntd.0009921","journal-title":"PLoS Negl Trop Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2021.1960822","article-title":"The rise of mucormycosis in Covid-19 patients in India","volume":"20","author":"Bhatia M","year":"2022","unstructured":"Bhatia M. The rise of mucormycosis in Covid-19 patients in India. Expert Rev Anti Infect Ther. 2022, 20:137-8. 10.1080\/14787210.2021.1960822","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0272042","article-title":"Hyperglycemia and steroid use increase the risk of rhino-orbito-cerebral mucormycosis regardless of COVID-19 hospitalization: case-control study, India","volume":"17","author":"Ponnaiah M","year":"2022","unstructured":"Ponnaiah M, Ganesan S, Bhatnagar T, et al.. Hyperglycemia and steroid use increase the risk of rhino-orbito-cerebral mucormycosis regardless of COVID-19 hospitalization: case-control study, India. PLoS One. 2022, 17:e0272042. 10.1371\/journal.pone.0272042","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-021-01840-w","article-title":"Mucormycosis in COVID-19 patients: predisposing factors, prevention and management","volume":"122","author":"Rudrabhatla PK","year":"2022","unstructured":"Rudrabhatla PK, Reghukumar A, Thomas SV. Mucormycosis in COVID-19 patients: predisposing factors, prevention and management. Acta Neurol Belg. 2022, 122:273-80. 10.1007\/s13760-021-01840-w","journal-title":"Acta Neurol Belg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.mjafi.2021.06.009","article-title":"Management outcomes of mucormycosis in COVID-19 patients: a preliminary report from a tertiary care hospital","volume":"77","author":"Kumari A","year":"2021","unstructured":"Kumari A, Rao NP, Patnaik U, et al.. Management outcomes of mucormycosis in COVID-19 patients: a preliminary report from a tertiary care hospital. Med J Armed Forces India. 2021, 77:S289-95. 10.1016\/j.mjafi.2021.06.009","journal-title":"Med J Armed Forces India"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2020.09.032","article-title":"Mucormycosis with orbital compartment syndrome in a patient with COVID-19","volume":"42","author":"Werthman-Ehrenreich A","year":"2021","unstructured":"Werthman-Ehrenreich A. Mucormycosis with orbital compartment syndrome in a patient with COVID-19. Am J Emerg Med. 2021, 42:264.e5-e8. 10.1016\/j.ajem.2020.09.032","journal-title":"Am J Emerg Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215121000992","article-title":"Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum","volume":"135","author":"Sharma S","year":"2021","unstructured":"Sharma S, Grover M, Bhargava S, Samdani S, Kataria T. Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum. J Laryngol Otol. 2021, 135:442-7. 10.1017\/S0022215121000992","journal-title":"J Laryngol Otol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-1748927","article-title":"COVID-19 associated mucormycosis with newly diagnosed diabetes mellitus in young males - a tertiary care experience","volume":"26","author":"Kapoor S","year":"2022","unstructured":"Kapoor S, Saidha PK, Gupta A, Saini U, Satya S. COVID-19 associated mucormycosis with newly diagnosed diabetes mellitus in young males - a tertiary care experience. Int Arch Otorhinolaryngol. 2022, 26:e470-7. 10.1055\/s-0042-1748927","journal-title":"Int Arch Otorhinolaryngol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/jof8030307","article-title":"Prevalence of COVID-19 associated mucormycosis in a German tertiary care hospital","volume":"8","author":"Scharmann U","year":"2022","unstructured":"Scharmann U, Herbstreit F, Steckel NK, Dedy J, Buer J, Rath PM, Verhasselt HL. Prevalence of COVID-19 associated mucormycosis in a German tertiary care hospital. J Fungi (Basel). 2022, 8:307. 10.3390\/jof8030307","journal-title":"J Fungi (Basel)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_2085_21","article-title":"COVID-19-associated mucormycosis: preliminary report from a tertiary eye care centre","volume":"69","author":"Walia S","year":"2021","unstructured":"Walia S, Bhaisare V, Rawat P, et al.. COVID-19-associated mucormycosis: preliminary report from a tertiary eye care centre. Indian J Ophthalmol. 2021, 69:3685-9. 10.4103\/ijo.IJO_2085_21","journal-title":"Indian J Ophthalmol"},{"key":"ref12","article-title":"Surviving mucormycosis: impact on psychological well-being and quality of life","volume":"3","author":"Singh A","year":"2021","unstructured":"Singh A, Gupta A. Surviving mucormycosis: impact on psychological well-being and quality of life. Acta Scientific Otolaryngology. 2021, 3:90-2.","journal-title":"Acta Scientific Otolaryngology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.27906","article-title":"COVID-19-associated mucormycosis in a tertiary care hospital in India: a case series","volume":"14","author":"Singh S","year":"2022","unstructured":"Singh S, Basera P, Anand A, Ozair A. COVID-19-associated mucormycosis in a tertiary care hospital in India: a case series. Cureus. 2022, 14:e27906. 10.7759\/cureus.27906","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/ijrc.ijrc_26_22","article-title":"Post- COVID mucormycosis: a retrospective observational study","volume":"11","author":"Shaik N","year":"2022","unstructured":"Shaik N, Bollam A, Konduri G, Sekhar AV. Post- COVID mucormycosis: a retrospective observational study. Indian J Respir Care. 2022, 11:230-3. 10.4103\/ijrc.ijrc_26_22","journal-title":"Indian J Respir Care"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.1083","article-title":"Frequency and survival of Covid associated mucormycosis patients at tertiary care hospitals in Pakistan: a retrospective observational study","volume":"6","author":"Irfan A","year":"2023","unstructured":"Irfan A, Kamran AH, Ammar M, Rahman SU. Frequency and survival of Covid associated mucormycosis patients at tertiary care hospitals in Pakistan: a retrospective observational study. Health Sci Rep. 2023, 6:e1083. 10.1002\/hsr2.1083","journal-title":"Health Sci Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s12070-021-02807-2","article-title":"Epidemiology, clinical features and management of rhino orbital mucormycosis in post COVID 19 patients","volume":"74","author":"Desai EJ","year":"2022","unstructured":"Desai EJ, Pandya A, Upadhya I, Patel T, Banerjee S, Jain V. Epidemiology, clinical features and management of rhino orbital mucormycosis in post COVID 19 patients. Indian J Otolaryngol Head Neck Surg. 2022, 74:103-7. 10.1007\/s12070-021-02807-2","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1172\/JCI42164","article-title":"The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice","volume":"120","author":"Liu M","year":"2010","unstructured":"Liu M, Spellberg B, Phan QT, et al.. The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice. J Clin Invest. 2010, 120:1914-24. 10.1172\/JCI42164","journal-title":"J Clin Invest"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI71349","article-title":"CotH3 mediates fungal invasion of host cells during mucormycosis","volume":"124","author":"Gebremariam T","year":"2014","unstructured":"Gebremariam T, Liu M, Luo G, et al.. CotH3 mediates fungal invasion of host cells during mucormycosis. J Clin Invest. 2014, 124:237-50. 10.1172\/JCI71349","journal-title":"J Clin Invest"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2021.06.008","article-title":"The surge in Covid related mucormycosis","volume":"83","author":"Chandra S","year":"2021","unstructured":"Chandra S, Rawal R. The surge in Covid related mucormycosis. J Infect. 2021, 83:381-412. 10.1016\/j.jinf.2021.06.008","journal-title":"J Infect"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s12070-021-02784-6","article-title":"Clinical study of surge of mucormycosis in COVID-19 pandemic: a tertiary care center study","volume":"74","author":"Gupta DP","year":"2022","unstructured":"Gupta DP, Gupta S, Shah CK, Sreevidya SR. Clinical study of surge of mucormycosis in COVID-19 pandemic: a tertiary care center study. Indian J Otolaryngol Head Neck Surg. 2022, 74:3455-62. 10.1007\/s12070-021-02784-6","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.31220","article-title":"Emergence of cerebral mucormycosis in the post-COVID period: a detailed analysis of risk factors, clinical progression, and management of this opportunistic fungal infection","volume":"14","author":"Patel M","year":"2022","unstructured":"Patel M, Panchal J, Desai C, Shah J, Prajapati B, Patel S. Emergence of cerebral mucormycosis in the post-COVID period: a detailed analysis of risk factors, clinical progression, and management of this opportunistic fungal infection. Cureus. 2022, 14:e31220. 10.7759\/cureus.31220","journal-title":"Cureus"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmmb.2021.05.009","article-title":"Rhinocerebral mucormycosis in COVID-19 patient with diabetes a deadly trio: case series from the north-western part of India","volume":"39","author":"Nehara HR","year":"2021","unstructured":"Nehara HR, Puri I, Singhal V, Ih S, Bishnoi BR, Sirohi P. Rhinocerebral mucormycosis in COVID-19 patient with diabetes a deadly trio: case series from the north-western part of India. Indian J Med Microbiol. 2021, 39:380-3. 10.1016\/j.ijmmb.2021.05.009","journal-title":"Indian J Med Microbiol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2021.103080","article-title":"The impact of COVID-19 outbreak on the incidence of acute invasive fungal rhinosinusitis","volume":"42","author":"Ismaiel WF","year":"2021","unstructured":"Ismaiel WF, Abdelazim MH, Eldsoky I, Ibrahim AA, Alsobky ME, Zafan E, Hasan A. The impact of COVID-19 outbreak on the incidence of acute invasive fungal rhinosinusitis. Am J Otolaryngol. 2021, 42:103080. 10.1016\/j.amjoto.2021.103080","journal-title":"Am J Otolaryngol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/jof8010044","article-title":"Dental and oral manifestations of COVID-19 related mucormycosis: diagnoses, management strategies and outcomes","volume":"8","author":"Janjua OS","year":"2021","unstructured":"Janjua OS, Shaikh MS, Fareed MA, Qureshi SM, Khan MI, Hashem D, Zafar MS. Dental and oral manifestations of COVID-19 related mucormycosis: diagnoses, management strategies and outcomes. J Fungi (Basel). 2021, 8:44. 10.3390\/jof8010044","journal-title":"J Fungi (Basel)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.102322","article-title":"COVID-19 associated mucormycosis: a descriptive multisite study from India","volume":"15","author":"Gupta R","year":"2021","unstructured":"Gupta R, Kesavadev J, Krishnan G, et al.. COVID-19 associated mucormycosis: a descriptive multisite study from India. Diabetes Metab Syndr. 2021, 15:102322. 10.1016\/j.dsx.2021.102322","journal-title":"Diabetes Metab Syndr"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3201\/eid2709.210934","article-title":"Multicenter epidemiologic study of coronavirus disease-associated mucormycosis, India","volume":"27","author":"Patel A","year":"2021","unstructured":"Patel A, Agarwal R, Rudramurthy SM, et al.. Multicenter epidemiologic study of coronavirus disease-associated mucormycosis, India. Emerg Infect Dis. 2021, 27:2349-59. 10.3201\/eid2709.210934","journal-title":"Emerg Infect Dis"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_1565_21","article-title":"Epidemiology,clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India\u2014Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1","volume":"69","author":"Sen M","year":"2021","unstructured":"Sen M, Honavar SG, Bansal R, et al.. Epidemiology,clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India\u2014Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1. Indian J Ophthalmol. 2021, 69:1670-92. 10.4103\/ijo.IJO_1565_21","journal-title":"Indian J Ophthalmol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2021.12.039","article-title":"Risk factors for coronavirus disease-associated mucormycosis","volume":"84","author":"Arora U","year":"2022","unstructured":"Arora U, Priyadarshi M, Katiyar V, et al.. Risk factors for coronavirus disease-associated mucormycosis. J Infect. 2022, 84:383-90. 10.1016\/j.jinf.2021.12.039","journal-title":"J Infect"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1101\/2021.08.16.21262109","article-title":"COVID-19 associated mucormycosis: a case-control study","volume":"081621262109","author":"Gupta D","year":"2021","unstructured":"Gupta D, Kulkarni R, Pujari S, Mulay A. COVID-19 associated mucormycosis: a case-control study. medRxiv. 2021, 081621262109:10.1101\/2021.08.16.21262109","journal-title":"medRxiv"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjid.2021.101597","article-title":"Is mucormycosis an inevitable complication of Covid-19 in India?","volume":"25","author":"Bhogireddy R","year":"2021","unstructured":"Bhogireddy R, Krishnamurthy V, Jabaris S SL, Pullaiah CP, Manohar S. Is mucormycosis an inevitable complication of Covid-19 in India?. Braz J Infect Dis. 2021, 25:101597. 10.1016\/j.bjid.2021.101597","journal-title":"Braz J Infect Dis"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27207","article-title":"Mucormycosis or black fungus infection is a new scare in South Asian countries during the COVID-19 pandemic: associated risk factors and preventive measures","volume":"93","author":"Rahman FI","year":"2021","unstructured":"Rahman FI, Islam MR, Bhuiyan MA. Mucormycosis or black fungus infection is a new scare in South Asian countries during the COVID-19 pandemic: associated risk factors and preventive measures. J Med Virol. 2021, 93:6447-8. 10.1002\/jmv.27207","journal-title":"J Med Virol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2021-140537","article-title":"Intercepting the deadly trinity of mucormycosis, diabetes and COVID-19 in India","volume":"98","author":"Banerjee M","year":"2022","unstructured":"Banerjee M, Pal R, Bhadada SK. Intercepting the deadly trinity of mucormycosis, diabetes and COVID-19 in India. Postgrad Med J. 2022, 98:e108-9. 10.1136\/postgradmedj-2021-140537","journal-title":"Postgrad Med J"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s12663-021-01532-1","article-title":"SARS-CoV-2, uncontrolled diabetes and corticosteroids-an unholy trinity in invasive fungal infections of the maxillofacial region? A retrospective, multi-centric analysis","volume":"20","author":"Moorthy A","year":"2021","unstructured":"Moorthy A, Gaikwad R, Krishna S, et al.. SARS-CoV-2, uncontrolled diabetes and corticosteroids-an unholy trinity in invasive fungal infections of the maxillofacial region? A retrospective, multi-centric analysis. J Maxillofac Oral Surg. 2021, 20:418-25. 10.1007\/s12663-021-01532-1","journal-title":"J Maxillofac Oral Surg"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.radcr.2020.09.026","article-title":"Bronchopleural fistula development in the setting of novel therapies for acute respiratory distress syndrome in SARS-CoV-2 pneumonia","volume":"15","author":"Placik DA","year":"2020","unstructured":"Placik DA, Taylor WL, Wnuk NM. Bronchopleural fistula development in the setting of novel therapies for acute respiratory distress syndrome in SARS-CoV-2 pneumonia. Radiol Case Rep. 2020, 15:2378-81. 10.1016\/j.radcr.2020.09.026","journal-title":"Radiol Case Rep"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.13163","article-title":"A case of fatal rhino-orbital mucormycosis associated with new onset diabetic ketoacidosis and COVID-19","volume":"13","author":"Waizel-Haiat S","year":"2021","unstructured":"Waizel-Haiat S, Guerrero-Paz JA, Sanchez-Hurtado L, Calleja-Alarcon S, Romero-Gutierrez L. A case of fatal rhino-orbital mucormycosis associated with new onset diabetic ketoacidosis and COVID-19. Cureus. 2021, 13:e13163. 10.7759\/cureus.13163","journal-title":"Cureus"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.102196","article-title":"Diabetes, COVID 19 and mucormycosis: clinical spectrum and outcome in a tertiary care medical center in Western India","volume":"15","author":"Mishra Y","year":"2021","unstructured":"Mishra Y, Prashar M, Sharma D, Akash, Kumar VP, Tilak TV. Diabetes, COVID 19 and mucormycosis: clinical spectrum and outcome in a tertiary care medical center in Western India. Diabetes Metab Syndr. 2021, 15:102196. 10.1016\/j.dsx.2021.102196","journal-title":"Diabetes Metab Syndr"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12474","article-title":"Mucormycosis in Iran: a systematic review","volume":"59","author":"Vaezi A","year":"2016","unstructured":"Vaezi A, Moazeni M, Rahimi MT, de Hoog S, Badali H. Mucormycosis in Iran: a systematic review. Mycoses. 2016, 59:402-15. 10.1111\/myc.12474","journal-title":"Mycoses"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2018.07.011","article-title":"The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports","volume":"25","author":"Jeong W","year":"2019","unstructured":"Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, Kong DC, Chen SC. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect. 2019, 25:26-34. 10.1016\/j.cmi.2018.07.011","journal-title":"Clin Microbiol Infect"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-017-4914-x","article-title":"Critical illness-related corticosteroid insufficiency (circi): a narrative review from a multispecialty task force of the Society of Critical Care Medicine (SCCM) and the European Society of Intensive Care Medicine (ESICM)","volume":"43","author":"Annane D","year":"2017","unstructured":"Annane D, Pastores SM, Arlt W, et al.. Critical illness-related corticosteroid insufficiency (circi): a narrative review from a multispecialty task force of the Society of Critical Care Medicine (SCCM) and the European Society of Intensive Care Medicine (ESICM). Intensive Care Med. 2017, 43:1781-92. 10.1007\/s00134-017-4914-x","journal-title":"Intensive Care Med"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3390\/jof5030069","article-title":"A guide to investigating suspected outbreaks of mucormycosis in healthcare","volume":"5","author":"Hartnett KP","year":"2019","unstructured":"Hartnett KP, Jackson BR, Perkins KM, et al.. A guide to investigating suspected outbreaks of mucormycosis in healthcare. J Fungi (Basel). 2019, 5:69. 10.3390\/jof5030069","journal-title":"J Fungi (Basel)"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.joclim.2022.100156","article-title":"The effects of climate change on fungal diseases with cutaneous manifestations: a report from the International Society of Dermatology Climate Change Committee","volume":"6","author":"Gadre A","year":"2022","unstructured":"Gadre A, Enbiale W, Andersen LK, Coates SJ. The effects of climate change on fungal diseases with cutaneous manifestations: a report from the International Society of Dermatology Climate Change Committee. J Clim Change Health. 2022, 6:100156. 10.1016\/j.joclim.2022.100156","journal-title":"J Clim Change Health"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.12.018","article-title":"Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis","volume":"27","author":"Langford BJ","year":"2021","unstructured":"Langford BJ, So M, Raybardhan S, et al.. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin Microbiol Infect. 2021, 27:520-31. 10.1016\/j.cmi.2020.12.018","journal-title":"Clin Microbiol Infect"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0251340","article-title":"Inappropriate antibiotic use in the COVID-19 era: factors associated with inappropriate prescribing and secondary complications. Analysis of the registry SEMI-COVID","volume":"16","author":"Calder\u00f3n-Parra J","year":"2021","unstructured":"Calder\u00f3n-Parra J, Mui\u00f1o-Miguez A, Bendala-Estrada AD, et al.. Inappropriate antibiotic use in the COVID-19 era: factors associated with inappropriate prescribing and secondary complications. Analysis of the registry SEMI-COVID. PLoS One. 2021, 16:e0251340. 10.1371\/journal.pone.0251340","journal-title":"PLoS One"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003682","article-title":"Sales of antibiotics and hydroxychloroquine in India during the COVID-19 epidemic: an interrupted time series analysis","volume":"18","author":"Sulis G","year":"2021","unstructured":"Sulis G, Batomen B, Kotwani A, Pai M, Gandra S. Sales of antibiotics and hydroxychloroquine in India during the COVID-19 epidemic: an interrupted time series analysis. PLoS Med. 2021, 18:e1003682. 10.1371\/journal.pmed.1003682","journal-title":"PLoS Med"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1099\/acmi.0.000360","article-title":"COVID-19-associated mucormycosis: case series from a tertiary care hospital in South India","volume":"4","author":"Rashbi K S","year":"2022","unstructured":"Rashbi K S, Ali TM, Deepthi ND, Saranya KS, Payyappilly RJ. COVID-19-associated mucormycosis: case series from a tertiary care hospital in South India. Access Microbiol. 2022, 4:acmi000360. 10.1099\/acmi.0.000360","journal-title":"Access Microbiol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.19455","article-title":"Evaluation of direct examination, culture, and histopathology in the diagnosis of mucormycosis: reiterating the role of Koh mount for early diagnosis","volume":"13","author":"Mohanty A","year":"2021","unstructured":"Mohanty A, Gupta P, Arathi K, et al.. Evaluation of direct examination, culture, and histopathology in the diagnosis of mucormycosis: reiterating the role of Koh mount for early diagnosis. Cureus. 2021, 13:e19455. 10.7759\/cureus.19455","journal-title":"Cureus"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(21)00237-8","article-title":"The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries","volume":"3","author":"Hoenigl M","year":"2022","unstructured":"Hoenigl M, Seidel D, Carvalho A, et al.. The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries. Lancet Microbe. 2022, 3:e543-52. 10.1016\/S2666-5247(21)00237-8","journal-title":"Lancet Microbe"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.3390\/jof5010026","article-title":"Global epidemiology of mucormycosis","volume":"5","author":"Prakash H","year":"2019","unstructured":"Prakash H, Chakrabarti A. Global epidemiology of mucormycosis. J Fungi (Basel). 2019, 5:26. 10.3390\/jof5010026","journal-title":"J Fungi (Basel)"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-021-00584-8","article-title":"Epidemiology and pathophysiology of COVID-19- associated mucormycosis: India versus the rest of the world","volume":"186","author":"Muthu V","year":"2021","unstructured":"Muthu V, Rudramurthy SM, Chakrabarti A, Agarwal R. Epidemiology and pathophysiology of COVID-19- associated mucormycosis: India versus the rest of the world. Mycopathologia. 2021, 186:739-54. 10.1007\/s11046-021-00584-8","journal-title":"Mycopathologia"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2021.111643","article-title":"Mucormycosis: an opportunistic pathogen during COVID-19","volume":"201","author":"Mahalaxmi I","year":"2021","unstructured":"Mahalaxmi I, Jayaramayya K, Venkatesan D, et al.. Mucormycosis: an opportunistic pathogen during COVID-19. Environ Res. 2021, 201:111643. 10.1016\/j.envres.2021.111643","journal-title":"Environ Res"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjoms.2021.06.013","article-title":"COVID-19 associated mucormycosis (CAM) in India: a formidable challenge","volume":"59","author":"Rao VU","year":"2021","unstructured":"Rao VU, Arakeri G, Madikeri G, Shah A, Oeppen RS, Brennan PA. COVID-19 associated mucormycosis (CAM) in India: a formidable challenge. Br J Oral Maxillofac Surg. 2021, 59:1095-8. 10.1016\/j.bjoms.2021.06.013","journal-title":"Br J Oral Maxillofac Surg"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_3774_20","article-title":"Mucor in a viral land: a tale of two pathogens","volume":"69","author":"Sen M","year":"2021","unstructured":"Sen M, Lahane S, Lahane TP, Parekh R, Honavar SG. Mucor in a viral land: a tale of two pathogens. Indian J Ophthalmol. 2021, 69:244-52. 10.4103\/ijo.IJO_3774_20","journal-title":"Indian J Ophthalmol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmicr.2021.100057","article-title":"Mucormycosis in COVID-19 pandemic: risk factors and linkages","volume":"2","author":"Kumar M","year":"2021","unstructured":"Kumar M, Sarma DK, Shubham S, et al.. Mucormycosis in COVID-19 pandemic: risk factors and linkages. Curr Res Microb Sci. 2021, 2:100057. 10.1016\/j.crmicr.2021.100057","journal-title":"Curr Res Microb Sci"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.05.005","article-title":"COVID-19-associated mucormycosis: an opportunistic fungal infection. A case series and review","volume":"121","author":"Balushi AA","year":"2022","unstructured":"Balushi AA, Ajmi AA, Sinani QA, et al.. COVID-19-associated mucormycosis: an opportunistic fungal infection. A case series and review. Int J Infect Dis. 2022, 121:203-10. 10.1016\/j.ijid.2022.05.005","journal-title":"Int J Infect Dis"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-022-00627-8","article-title":"Clinical features and mortality of COVID-19-associated mucormycosis: a systematic review and meta-analysis","volume":"187","author":"Watanabe A","year":"2022","unstructured":"Watanabe A, So M, Mitaka H, et al.. Clinical features and mortality of COVID-19-associated mucormycosis: a systematic review and meta-analysis. Mycopathologia. 2022, 187:271-89. 10.1007\/s11046-022-00627-8","journal-title":"Mycopathologia"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/185909-the-second-covid-19-wave-is-a-tsunami-with-aftershocks-mucormycosis-ire-as-seen-in-a-tertiary-care-hospital-in-uttarakhand-india","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:11:03Z","timestamp":1707509463000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/185909-the-second-covid-19-wave-is-a-tsunami-with-aftershocks-mucormycosis-ire-as-seen-in-a-tertiary-care-hospital-in-uttarakhand-india"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,20]]},"references-count":55,"URL":"https:\/\/doi.org\/10.7759\/cureus.47358","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,20]]}}}